Srinivas Akkaraju

Insider Reports History

Entity
Individual
Location
565 Everett Avenue, Palo Alto, CA
Signature
/s/ Srinivas Akkaraju
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Srinivas Akkaraju:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. Director, 10%+ Owner Common Stock 5.07M $68.5M $13.50 Feb 12, 2024 Indirect
Scholar Rock Holding Corp Director Common Stock 6.28M $53.9M $8.59 Oct 7, 2024 Samsara BioCapital, L.P.
ALUMIS INC. Director Common Stock 3.27M $52.3M $16.00 Jul 1, 2024 By Samsara BioCapital, L.P.
Scholar Rock Holding Corp Director Common Stock 5.61M $48.2M $8.59 Oct 7, 2024 By Samsara BioCapital, L.P.
vTv Therapeutics Inc. Director, 10%+ Owner Pre- Funded Warrants (Right to Buy) 893K $10.5M $11.80 Mar 5, 2024 Samsara BioCapital, L.P.
vTv Therapeutics Inc. Director, 10%+ Owner Class A Common Stock 207K $3.51M $16.96 Mar 5, 2024 By Samsara BioCapital, L.P.
Scholar Rock Holding Corp Director Common Stock 13.5K $116K $8.59 Oct 7, 2024 Direct
vTv Therapeutics Inc. Director, 10%+ Owner Stock Option (Right to Buy) 3.75K $44.3K $11.81 Feb 27, 2024 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 9.33K $15.6K $1.68 Sep 16, 2024 Direct
Syros Pharmaceuticals, Inc. Director Restricted Stock Units 2.67K $4.47K $1.68 Sep 16, 2024 Direct
Jiya Acquisition Corp. Director, 10%+ Owner Class B Common Stock 2.44M Sep 23, 2022 Indirect
Mineralys Therapeutics, Inc. Director, 10%+ Owner Stock Option 22K May 22, 2024 Direct
Scholar Rock Holding Corp Director Stock Option (Right to Buy) 18K Jun 27, 2024 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6K Jun 5, 2024 Direct
ALUMIS INC. Director Class A Common Stock 0 Jul 1, 2024 By Samsara BioCapital, L.P.
ALUMIS INC. Director Series C Preferred Stock 0 Jul 1, 2024 By Samsara BioCapital, L.P.
CHINOOK THERAPEUTICS, INC. Director Common Stock 0 $39.03 Aug 11, 2023 By Samsara BioCapital, L.P.
CHINOOK THERAPEUTICS, INC. Director Common Stock 0 $39.03 Aug 11, 2023 Direct
CHINOOK THERAPEUTICS, INC. Director Stock Option (Right to Buy) 0 $26.12 Aug 11, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Indirect
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 Nov 8, 2023 Direct

Insider Reports Filed by Srinivas Akkaraju

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRRK Scholar Rock Holding Corp Oct 7, 2024 3 -$34.4M 4 Oct 7, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2024 2 $0 4 Sep 18, 2024 Director
ALMS ALUMIS INC. Jul 1, 2024 1 $25M 4/A Aug 27, 2024 Director
SRRK Scholar Rock Holding Corp Jun 27, 2024 2 $0 4 Jul 1, 2024 Director
ALMS ALUMIS INC. Jun 27, 2024 0 $0 3 Jun 27, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2024 2 $0 4 Jun 4, 2024 Director
MLYS Mineralys Therapeutics, Inc. May 22, 2024 1 $0 4 May 23, 2024 Director, 10%+ Owner
VTVT vTv Therapeutics Inc. Mar 5, 2024 2 $0 4 Dec 6, 2024 Director, 10%+ Owner
VTVT vTv Therapeutics Inc. Feb 27, 2024 1 $0 4 Jun 13, 2024 Director, 10%+ Owner
VTVT vTv Therapeutics Inc. Feb 27, 2024 2 $12.5M 4 Feb 29, 2024 Director, 10%+ Owner
VTVT vTv Therapeutics Inc. Feb 23, 2024 0 $0 3 Feb 29, 2024 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 12, 2024 1 $7.5M 4 Feb 14, 2024 Director, 10%+ Owner
SYRS Syros Pharmaceuticals, Inc. Dec 21, 2023 1 $4M 4 Dec 26, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 13 -$13M 4 Nov 13, 2023 Director
SRRK Scholar Rock Holding Corp Oct 16, 2023 1 $15M 4 Oct 18, 2023 Director, 10%+ Owner
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2023 2 $0 4 Sep 19, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Aug 11, 2023 5 -$1.08M 4 Aug 11, 2023 Director
SRRK Scholar Rock Holding Corp Jun 21, 2023 1 $0 4 Jun 22, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2023 2 $0 4 May 31, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 24, 2023 2 $0 4 May 25, 2023 Director
MLYS Mineralys Therapeutics, Inc. Feb 14, 2023 4 $15M 4 Feb 16, 2023 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 0 $0 3 Feb 9, 2023 Director, 10%+ Owner
JYAC Jiya Acquisition Corp. Sep 23, 2022 1 $0 4 Sep 23, 2022 Director, 10%+ Owner
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2022 4 $0 4/A Apr 20, 2023 Director
SRRK Scholar Rock Holding Corp Sep 16, 2022 1 $0 4 Sep 20, 2022 Director
SRRK Scholar Rock Holding Corp Jul 26, 2022 0 $0 3 Jul 28, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. May 27, 2022 1 $7.98M 4 Jun 1, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2022 2 $0 4 May 31, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 25, 2022 2 $0 4 May 27, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. Nov 15, 2021 1 $17M 4 Nov 17, 2021 Director
JYAC Jiya Acquisition Corp. Sep 23, 2021 2 $0 4 Sep 27, 2021 Director, 10%+ Owner
JYAC Jiya Acquisition Corp. Aug 26, 2021 1 $0 4 Aug 30, 2021 Director, 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. Aug 18, 2021 1 $2.5M 4 Aug 20, 2021 Director
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
KDNY CHINOOK THERAPEUTICS, INC. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 27, 2021 2 $0 4 Jun 1, 2021 Director